Zojer Niklas, Ludwig Heinz, Fiegl Michael, Stevenson Freda K, Sahota Surinder S
Molecular Immunology Group, Tenovus Laboratory, Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom.
Blood. 2003 May 15;101(10):4137-9. doi: 10.1182/blood-2002-09-2825. Epub 2003 Jan 16.
Monoclonal gammopathy of undetermined significance (MGUS) can transform to multiple myeloma (MM). In myeloma, mutated V(H) genes with sequence homogeneity reveal a postfollicular origin. Previously, some MGUS cases showed mutated V(H) genes with intraclonal variation, indicating an earlier stage of arrest. We investigated progression from 2 of 2 MGUS to MM, in which V(H) genes confirmed clonal evolution. In one MGUS case, intraclonal heterogeneity was evident, and transformation to myeloma occurred rapidly with apparent homogeneity in the emergent clone. However, residual MGUS-derived sequences were detectable at this time. Heterogeneity in MGUS does not associate with benign disease, but it indicates an origin from a tumorigenic cell, most likely surface immunoglobulin(+), undergoing somatic mutation. The remaining case displayed intraclonal homogeneity at the MGUS stage, conceivably resulting from a self-cloning outgrowth from MGUS with heterogeneity. Transformation can occur at either MGUS stage, but it involves a single cell in which somatic mutation is then silent.
意义未明的单克隆丙种球蛋白病(MGUS)可转化为多发性骨髓瘤(MM)。在骨髓瘤中,具有序列同源性的突变V(H)基因显示出滤泡后起源。此前,一些MGUS病例显示出具有克隆内变异的突变V(H)基因,表明处于更早的停滞阶段。我们研究了2例MGUS向MM的进展情况,其中V(H)基因证实了克隆进化。在1例MGUS病例中,克隆内异质性明显,向骨髓瘤的转化迅速发生,新出现的克隆具有明显的同源性。然而,此时仍可检测到残留的MGUS衍生序列。MGUS中的异质性与良性疾病无关,但它表明起源于一个致瘤细胞,很可能是表面免疫球蛋白(+)细胞,正在经历体细胞突变。其余病例在MGUS阶段表现为克隆内同源性,这可能是由具有异质性的MGUS自我克隆生长所致。转化可发生在任何一个MGUS阶段,但它涉及一个体细胞突变随后沉默的单个细胞。